At Hansa, we are dedicated to creating a material change for people living with rare immunological diseases. We leverage our immunomodulatory platform to develop treatments which enable transplantations and advance research in disease areas such as rare immunoglobulin G (IgG)-mediated autoimmune conditions, gene therapy and cancer. Our first product in kidney transplantation has been granted conditional authorization in the European Union (EU)/EAA and United Kingdom (UK).
We are a fast-growing, R&D-driven biopharmaceutical company, with a mission to develop innovative, lifesaving and life-altering immunomodulating therapies, ultimately bringing them to patients with rare diseases where previously their needs were unmet. We aim to add value to society at large.
By empowering our people and working in an agile way we move our projects forward with high speed, efficiency and scientific excellence. We strive to attract leading talent from around the world, broaden our network of partners and establish a presence in key markets around the world. There are many opportunities for highly qualified, motivated, and passionate team players to join us on our exciting journey.